Results of Transfemoral or Transapical Aortic Valve Implantation Following a Uniform Assessment in High-Risk Patients With Aortic Stenosis

Journal of the American College of Cardiology

Volumn 54, Issue 4, 2009, Pages 303-311

  Himbert, Dominique ^a   Descoutures, Fleur ^a   Al Attar, Nawwar ^a   Iung, Bernard ^a   Ducrocq, Gregory ^a   Détaint, Delphine ^a   Brochet, Eric ^a   Messika Zeitoun, David ^a   Francis, Fady ^a   Ibrahim, Hassan ^a   Nataf, Patrick ^a   Vahanian, Alec ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

aortic stenosis; high risk; transapical; transcatheter aortic valve implantation; transfemoral

Indexed keywords

AGED; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTERY DISSECTION; ARTERY INJURY; ARTERY THROMBOSIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; CAUSE OF DEATH; CLINICAL EVALUATION; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE SEVERITY; FEMALE; FEMORAL ARTERY; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART LEFT VENTRICLE ANEURYSM; HEART TAMPONADE; HEMATOMA; HEMOPERICARDIUM; HIGH RISK POPULATION; HUMAN; ILIAC ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERICARDIAL EFFUSION; POSTOPERATIVE COMPLICATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; SCORING SYSTEM; STROKE; SURGICAL APPROACH; SURGICAL DRAINAGE; SURGICAL RISK; SURVIVAL RATE; TRANSAPICAL APPROACH; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSFEMORAL APPROACH;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; FEMALE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; RISK FACTORS; TREATMENT OUTCOME;

EID: 67650088413     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.04.032     Document Type: Article

References (29)

1. Iung B., Baron G., Butchart E.G., et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular disease. Eur Heart J 24 (2003) 1231-1243
2. Iung B., Cachier A., Baron G., et al. Decision making in elderly patients with severe aortic stenosis: why are so many denied surgery?. Eur Heart J 26 (2005) 2714-2720
3. Cribier A., Eltchaninoff H., Bash A., et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106 (2002) 3006-3008
4. Cribier A., Eltchaninoff H., Tron C., et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 43 (2004) 698-703
5. Cribier A., Eltchaninoff H., Tron C., et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 47 (2006) 1214-1223
6. Webb J., Chandavimol M., Thompson C.R., et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113 (2006) 842-850
7. Webb J.G., Pasupati S., Humphries K., et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116 (2007) 755-763
8. Grube E., Laborde J.C., Gerckens U., et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease. The Sieburg first-in-man study. Circulation 114 (2006) 1616-1624
9. Grube E., Schuler G., Buellesfeld L., et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis. Device success and 30-day clinical outcome. J Am Coll Cardiol 50 (2007) 69-76
10. Piazza N., Grube E., Gerckens U., et al., clinical centres who actively participated in the registry. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroInterv 4 (2008) 242-249
11. Walther T., Falk V., Borger M.A., et al. Minimally invasive transventricular beating heart aortic valve implantation-proof of concept. Eur J Cardio Thor Surg 31 (2007) 9-15
12. Walther T., Simon P., Dewey T., et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 116 (2007) I240-I245
13. Ye J., Cheung A., Lichtenstein S.V., et al. Six-month outcome of transventricular transcatheter aortic valve implantation in the initial seven patients. Eur J Cardio Thor Surg 31 (2007) 16-21
14. Svensson L.G., Dewey T., Kapadia S., et al. United States feasibility of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 86 (2008) 46-55
15. Eltchaninoff H., Zajarias A., Tron C., et al. Transcatheter aortic valve implantation: technical aspects, results and indications. Arch Cardiovasc Dis 101 (2008) 126-132
16. Descoutures F., Himbert D., Lepage L., et al. Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly. Eur Heart J 29 (2008) 1410-1417
17. Vahanian A., Alfieri O., Al-Attar N., et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 29 (2008) 1463-1470
18. Rodés-Cabau J., Dumont E., De LaRochellière R., et al. Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am J Cardiol 102 (2008) 1240-1246
19. Rockwood K., Stadnyck K., MacKnight C., McDowell I., Herbert R., and Hogan D.B. A brief clinical instrument to clarify frailty in elderly people. Lancet 353 (1999) 205-206
20. Lee S.J., Lindquist K., Segal M.R., and Covinsky K.E. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 295 (2006) 801-808
21. Zedgi R., Ciobotaru V., Noghin M., et al. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent?. J Am Coll Cardiol 51 (2008) 579-584
22. Akins C.W., Miller C., Turina M.I., et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg 135 (2008) 732-738
23. Otten A.M., van Domburg R.T., van Gameren M., et al. Population characteristics, treatment assignment and survival of patients with aortic stenosis referred for percutaneous valve replacement. EuroInterv 4 (2008) 250-255
24. Bonow R.O., Carabello B.A., Chatterjee K., et al. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Valvular Heart Disease). J Am Coll Cardiol 48 (2006) e1-e148
25. Vahanian A., Baumgartner H., Bax J., et al. Guidelines on the management of valvular heart disease. The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 28 (2007) 230-268
26. Kolh P., Kerzmann A., Honore C., Comte L., and Limet R. Aortic valve surgery in octogenarians: predictive factors for operative and long-term results. Eur J Cardiothorac Surg 31 (2006) 600-606
27. Edwards M.B., and Taylor K.M. Outcomes in nonagenarians after heart valve replacement operation. Ann Thorac Surg 75 (2003) 830-834
28. Dewey T.M., Brown D., Ryan W.H., Herbert M.A., Prince S.L., and Mack M.J. Reliability of risk algorithms in predicting early and late operative outcomes in high risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 135 (2008) 180-187
29. Grossi E.A., Schwartz C.F., Yu P.J., et al. High-risk aortic valve replacement: are outcomes as bad as predicted?. Ann Thorac Surg 85 (2008) 102-106